Project Grant K08HS029693

Award Date 9/30/24
Completion Date 9/29/29
Dollars Obligated $149K
Awarding Federal Agency
Division of Grants Management
Federal Grant Program
93.226
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This $400,000 Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund the dissemination of a facilitation strategy to deimplement unnecessary post-operative antibiotic use at 20 U.S. children's hospitals. The principal awardee, the Research Institute at Nationwide Children's Hospital (RINCH), will adapt their existing evidence-based facilitation strategy into synchronous and...
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) awarded a $999,998 Project Grant under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program to Northwestern University. The grant funds a 5-year mixed methods study to evaluate the implementation of antibiotic stewardship (AS) strategies and health equity standards in urgent care clinics and federally qualified health centers. Key objectives include assessing disparities in...
The Project Grant award K08HS030118, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports research to identify sepsis phenotypes associated with antibiotic-resistant pathogens. The $294,244 award, effective from August 1, 2024 to July 31, 2029, will be conducted by the primary awardee, The General Hospital Corporation (doing business as Massachusetts General Hospital). The key objectives of...
This federal Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) aims to improve outpatient antimicrobial stewardship by assessing and implementing risk-stratified penicillin allergy evaluation in key settings including surgical, transplant, and obstetric care. The $490,523 award to Vanderbilt University Medical Center will: 1) measure the efficacy, barriers, and facilitators of...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program provides $153,050 to fund a 5-year research initiative led by Boston Children's Hospital. The project aims to develop and implement a machine learning-based clinical decision support system to promptly identify high-risk pediatric urinary tract infections (UTIs) and improve the optimal timing of voiding cystourethrogram (VCUG)...
This $275,000 federal Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund research to increase implementation of evidence-based interventions by patient advocacy groups. The grant recipient, the University of Texas Health Science Center at Houston, will: Develop and test strategies to increase implementation of consensus treatment plans for juvenile idiopathic arthritis in...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will provide $154,862 to Duke University to conduct research on short-course ampicillin use in preterm infants. The goal is to develop methods to safely limit unnecessary antibiotic exposures in this population, which can cause morbidity and mortality. The award will enable the principal investigator, Dr....
This $194,400 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will fund research led by Dr. Albin at the University of Michigan to: Identify unique biomarkers in the lungs that can guide personalized treatment durations for ventilator-associated pneumonia (VAP), a common and serious infection affecting hospitalized patients. Validate analytical methods for future...
This Project Grant award of $873,716 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate the effectiveness of the CARE, Review, Assessment and Feedback Tool (CRAFT) intervention to reduce unnecessary antibiotic prescribing for acute upper respiratory infections (URIs) in unscheduled outpatient care settings. The project, led by Vanderbilt University Medical Center, will adapt the previously piloted...
This federal Project Grant award, provided by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, will fund the development and implementation of a machine learning-based clinical decision support (CDS) tool to reduce laboratory test overutilization in pediatric intensive care units (PICUs). The $172,785 award, with an expected completion date of July 31, 2026, will enable the University of Rochester to...

This $148,882 Project Grant award under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, funded by the Agency for Healthcare Research and Quality (AHRQ), supports research to implement antibiotic stewardship strategies and increase the use of oral antibiotics for children hospitalized with pneumonia. The principal investigator, Dr. Jillian Cotter, will conduct a pilot hybrid trial to evaluate the feasibility and acceptability of implementation strategies to promote initial oral antibiotic use. This research aims to address the gap between evidence and practice, as most hospitalized children with pneumonia still receive intravenous antibiotics despite oral therapy being equally effective. The project will identify barriers and facilitators to increasing oral antibiotic use, develop implementation strategies, and gather data on the effectiveness of oral versus intravenous therapy. This work will prepare Dr. Cotter to submit an R01 grant for a multisite study to further evaluate implementation and effectiveness outcomes. The award supports Dr. Cotter's career development as an independently funded investigator and national leader in antibiotic stewardship practices.

Generated 5/13/25, 3:41 AM